2016 updated EULAR evidence-based recommendations for the management of gout
Background New drugs and new evidence concerning the use of established treatments
have become available since the publication of the first European League Against …
have become available since the publication of the first European League Against …
2023 ESH Guidelines for the management of arterial hypertension The Task Force for the management of arterial hypertension of the European Society of …
G Mancia, R Kreutz, M Brunström, M Burnier… - Journal of …, 2023 - journals.lww.com
Document Reviewers: Luis Alcocer (Mexico), Christina Antza (Greece), Mustafa Arici
(Turkey), Eduardo Barbosa (Brazil), Adel Berbari (Lebanon), Luıs Bronze (Portugal), John …
(Turkey), Eduardo Barbosa (Brazil), Adel Berbari (Lebanon), Luıs Bronze (Portugal), John …
Role of comorbidities in heart failure prognosis Part 2: Chronic kidney disease, elevated serum uric acid
A Tedeschi, P Agostoni, B Pezzuto… - European journal of …, 2020 - journals.sagepub.com
Despite improvements in pharmacotherapy, morbidity and mortality rates in community-
based populations with chronic heart failure still remain high. The increase in medical …
based populations with chronic heart failure still remain high. The increase in medical …
[PDF][PDF] 2023 ESH Guidelines for the management of arterial hypertension The Task Force for the management of arterial hypertension of the European Society of …
M Brunström, M Burnier… - Journal of …, 2023 - docred-strapi-cms-prod.s3.sa-east-1 …
Document Reviewers: Luis Alcocer (Mexico), Christina Antza (Greece), Mustafa Arici
(Turkey), Eduardo Barbosa (Brazil), Adel Berbari (Lebanon), Luıs Bronze (Portugal), John …
(Turkey), Eduardo Barbosa (Brazil), Adel Berbari (Lebanon), Luıs Bronze (Portugal), John …
Mediators of ertugliflozin effects on heart failure and kidney outcomes among patients with type 2 diabetes mellitus
MW Segar, AA Kolkailah, R Frederich… - Diabetes, Obesity …, 2022 - Wiley Online Library
Aims Sodium‐glucose cotransporter 2 (SGLT2) inhibitors have been shown to reduce the
risk of hospitalization for heart failure (HHF) and composite kidney outcomes, but the …
risk of hospitalization for heart failure (HHF) and composite kidney outcomes, but the …
[HTML][HTML] Uric acid and cardiovascular disease: an update
ML Muiesan, C Agabiti-Rosei, A Paini… - European Cardiology …, 2016 - ncbi.nlm.nih.gov
In recent years, serum uric acid (SUA) as a determinant of cardiovascular (CV) risk has
gained interest. Epidemiological, experimental and clinical data show that patients with …
gained interest. Epidemiological, experimental and clinical data show that patients with …
How the Mediterranean diet and some of its components modulate inflammatory pathways in arthritis
F Oliviero, P Spinella, U Fiocco, R Ramonda… - Swiss medical …, 2015 - smw.ch
Arthritis encompasses a heterogeneous group of diseases characterised by inflammation
that leads not only to joint damage, bone erosion, severe pain and disability, but also affects …
that leads not only to joint damage, bone erosion, severe pain and disability, but also affects …
[HTML][HTML] Hyperuricemia and cardiovascular risk
L Shahin, KM Patel, MK Heydari, MM Kesselman - Cureus, 2021 - ncbi.nlm.nih.gov
As the prevalence of hyperuricemia (elevated uric acid levels in the blood) increases, the
relationship between serum uric acid levels and cardiovascular risk has garnered increased …
relationship between serum uric acid levels and cardiovascular risk has garnered increased …
Clinical implications of uric acid in heart failure: a comprehensive review
Affecting more than 26 million people worldwide and with rising prevalence, heart failure
(HF) represents a major global health problem. Hence, further research is needed in order to …
(HF) represents a major global health problem. Hence, further research is needed in order to …
Serum uric acid and cardiometabolic disease: another brick in the wall?
C Borghi, AFG Cicero - Hypertension, 2017 - Am Heart Assoc
1012 Hypertension June 2017 urate levels. The predominant role of a mechanism linking
the production of uric acid to oxidative stress can reasonably explain the evidence of an …
the production of uric acid to oxidative stress can reasonably explain the evidence of an …